Difference between revisions of "Gawlitza A"
From Bioblast
m (moved Gawlitza Alexander to Gawlitza A) |
Nirschl Lisa (talk | contribs) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 10: | Line 10: | ||
}} | }} | ||
{{Labelingperson}} | {{Labelingperson}} | ||
== Participated at == | |||
::::* [[IOC96| IOC96 Schroecken AT]] | |||
Latest revision as of 12:11, 13 February 2018
| Name | Gawlitza Alexander, |
|---|---|
| Institution | University Medical Center of Mainz |
| Address | Langenbeckstraße 1, D–55131 |
| City | Mainz |
| State/Province | |
| Country | Germany |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | DE Mainz Methner A |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Lisak 2015 Cell Death Differ | 2015 | Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, Parys JB, De Smedt H, Kindler T, Adams-Quack P, Hahn M, Waisman A, Reed JC, Hövelmeyer N, Methner A (2015) BAX inhibitor-1 is a Ca2+ channel critically important for immune cell function and survival. Cell Death Differ 23:358-68. |
Abstracts
